Cargando…

Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk

Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Adam, Jackson, Nicholas J., Cheng, Eric M., Bryg, Robert J., Brown, Arleen, Towfighi, Amytis, Sanossian, Nerses, Barry, Frances, Li, Ning, Vickrey, Barbara G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185059/
https://www.ncbi.nlm.nih.gov/pubmed/32200759
http://dx.doi.org/10.1161/STROKEAHA.119.027160
_version_ 1783526692732534784
author Richards, Adam
Jackson, Nicholas J.
Cheng, Eric M.
Bryg, Robert J.
Brown, Arleen
Towfighi, Amytis
Sanossian, Nerses
Barry, Frances
Li, Ning
Vickrey, Barbara G.
author_facet Richards, Adam
Jackson, Nicholas J.
Cheng, Eric M.
Bryg, Robert J.
Brown, Arleen
Towfighi, Amytis
Sanossian, Nerses
Barry, Frances
Li, Ning
Vickrey, Barbara G.
author_sort Richards, Adam
collection PubMed
description Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. METHODS—: We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. RESULTS—: The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. CONCLUSIONS—: A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. REGISTRATION—: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081.
format Online
Article
Text
id pubmed-7185059
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-71850592020-05-01 Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk Richards, Adam Jackson, Nicholas J. Cheng, Eric M. Bryg, Robert J. Brown, Arleen Towfighi, Amytis Sanossian, Nerses Barry, Frances Li, Ning Vickrey, Barbara G. Stroke Original Contributions Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. METHODS—: We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. RESULTS—: The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. CONCLUSIONS—: A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. REGISTRATION—: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081. Lippincott Williams & Wilkins 2020-05 2020-03-23 /pmc/articles/PMC7185059/ /pubmed/32200759 http://dx.doi.org/10.1161/STROKEAHA.119.027160 Text en © 2020 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Original Contributions
Richards, Adam
Jackson, Nicholas J.
Cheng, Eric M.
Bryg, Robert J.
Brown, Arleen
Towfighi, Amytis
Sanossian, Nerses
Barry, Frances
Li, Ning
Vickrey, Barbara G.
Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title_full Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title_fullStr Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title_full_unstemmed Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title_short Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
title_sort derivation and application of a tool to estimate benefits from multiple therapies that reduce recurrent stroke risk
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185059/
https://www.ncbi.nlm.nih.gov/pubmed/32200759
http://dx.doi.org/10.1161/STROKEAHA.119.027160
work_keys_str_mv AT richardsadam derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT jacksonnicholasj derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT chengericm derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT brygrobertj derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT brownarleen derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT towfighiamytis derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT sanossiannerses derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT barryfrances derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT lining derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk
AT vickreybarbarag derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk